OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
402156

Canadian General Medical Center Complex Company SJSC

Healthcare Facilities & ServicesVerified

The company maintains a strong liquidity position with a current ratio of 4.0, indicating a robust ability to meet short-term obligations. However, the free cash flow is negative at -41,310 SAR, suggesting that capital expenditures are outpacing operating cash flow. The debt-to-equity ratio is low at 0.06, reflecting a conservative capital structure with minimal leverage. Profitability metrics show a return on equity of 10.93% and a return on assets of 7.89%, which are strong indicators of efficient asset utilization and profitability. These figures are in line with the industry's preferred metrics, emphasizing the importance of maintaining high operational efficiency in the healthcare sector. The company operates as a single segment, providing medical services across Saudi Arabia, with a focus on ambulance services and medical centers. Revenue is concentrated within the Kingdom, with no disclosed international operations. This geographic concentration may expose the company to regional economic fluctuations. Looking ahead, the company is projected to maintain a stable growth trajectory, with no significant changes in revenue expected in the next fiscal year. Historical revenue data indicates a consistent performance, with a total revenue of 148,231,290 SAR in the latest reporting period. Risk factors include a medium liquidity risk due to the negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no immediate pressure for share issuance. The company has not disclosed any recent events that would significantly impact its operations or financial position.

30-day price · 4021-0.59 (-10.1%)
Low$5.21High$6.10Close$5.24As of12 May, 00:00 UTC
Profile
CompanyCanadian General Medical Center Complex Company SJSC
Ticker4021.SE
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Canadian General Medical Center Complex Company SJSC operates in the healthcare sector in Saudi Arabia, providing medical services through three centers in Khobar, Dammam, and Buqayq, along with ambulance services and medical training.

Classification. The company is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a confidence level of 0.92.

The company maintains a strong liquidity position with a current ratio of 4.0, indicating a robust ability to meet short-term obligations. However, the free cash flow is negative at -41,310 SAR, suggesting that capital expenditures are outpacing operating cash flow. The debt-to-equity ratio is low at 0.06, reflecting a conservative capital structure with minimal leverage. Profitability metrics show a return on equity of 10.93% and a return on assets of 7.89%, which are strong indicators of efficient asset utilization and profitability. These figures are in line with the industry's preferred metrics, emphasizing the importance of maintaining high operational efficiency in the healthcare sector. The company operates as a single segment, providing medical services across Saudi Arabia, with a focus on ambulance services and medical centers. Revenue is concentrated within the Kingdom, with no disclosed international operations. This geographic concentration may expose the company to regional economic fluctuations. Looking ahead, the company is projected to maintain a stable growth trajectory, with no significant changes in revenue expected in the next fiscal year. Historical revenue data indicates a consistent performance, with a total revenue of 148,231,290 SAR in the latest reporting period. Risk factors include a medium liquidity risk due to the negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no immediate pressure for share issuance. The company has not disclosed any recent events that would significantly impact its operations or financial position.
Key takeaways
  • The company has a strong liquidity position with a current ratio of 4.0.
  • Profitability is robust, with a return on equity of 10.93% and a return on assets of 7.89%.
  • The company operates as a single segment with a focus on medical services in Saudi Arabia.
  • Growth is expected to remain stable with no significant changes in revenue projected.
  • The company maintains a conservative capital structure with a low debt-to-equity ratio of 0.06.
  • The risk of dilution is low, and there are no immediate pressures for share issuance.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencySAR
Revenue$148.2M
Gross profit$43.5M
Operating income$18.1M
Net income$10.5M
R&D
SG&A
D&A
SBC
Operating cash flow$19.9M
CapEx-$9.4M
Free cash flow-$41.3k
Total assets$133.0M
Total liabilities$37.0M
Total equity$96.1M
Cash & equivalents
Long-term debt$6.0M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$96.1M
Net cash-$6.0M
Current ratio4.0
Debt/Equity0.1
ROA7.9%
ROE10.9%
Cash conversion1.9%
CapEx/Revenue-6.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Pharmaceuticals · cohort 25 companies
Metric4021Activity
Op margin12.2%18.2% medp25 18.2% · p75 24.6%bottom quartile
Net margin7.1%14.7% medp25 11.7% · p75 28.1%bottom quartile
Gross margin29.3%19.7% medp25 19.7% · p75 39.8%above median
R&D / revenue24.3% medp25 6.6% · p75 24.3%
CapEx / revenue-6.3%4.9% medp25 4.2% · p75 6.3%bottom quartile
Debt / equity6.0%71.3% medp25 19.0% · p75 91.7%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-15 18:02 UTC#16ec4d78
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 13:33 UTCJob: 857873d1